<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>ir-100-16825</identifier><datestamp>2014-12-28T15:04:24Z</datestamp><dc:title>Biphasic magnetic nanoparticles-nanovesicle hybrids for chemotherapy and self-controlled hyperthermia</dc:title><dc:creator>GOGOI, M</dc:creator><dc:creator>SARMA, HD</dc:creator><dc:creator>BAHADUR, D</dc:creator><dc:creator>BANERJEE, R</dc:creator><dc:subject>biphasic suspension</dc:subject><dc:subject>cancer</dc:subject><dc:subject>chemotherapy</dc:subject><dc:subject>magnetic nanovesicle</dc:subject><dc:subject>self-controlled hyperthermia</dc:subject><dc:subject>POLY(ETHYLENE GLYCOL)</dc:subject><dc:subject>CATIONIC LIPOSOMES</dc:subject><dc:subject>TUMOR VASCULATURE</dc:subject><dc:subject>IN-VIVO</dc:subject><dc:subject>DRUG-DELIVERY</dc:subject><dc:subject>CELL-DEATH</dc:subject><dc:subject>THERAPY</dc:subject><dc:subject>PACLITAXEL</dc:subject><dc:subject>CYTOTOXICITY</dc:subject><dc:subject>CHOLESTEROL</dc:subject><dc:description>Aim: The aim was to develop magnetic nanovesicles for chemotherapy and self-controlled hyperthermia that prevent overheating of tissues. Materials &amp; methods: Magnetic nanovesicles containing paclitaxel and a dextran-coated biphasic suspension of La0.75Sr0.25MnO3 and Fe3O4 nanoparticles (magnetic nanoparticles) were developed. Results: Encapsulation efficiencies of magnetic nanoparticles and paclitaxel were 67 +/- 5 and 83 +/- 3%, respectively. Sequential release performed at 37 degrees C for 1 h followed by 44 degrees C for another 1 h (as expected for intratumoral injection), showed a cumulative release of 6.6% (109.6 mu g), which was above the IC50 of the drug. In an alternating current magnetic field, the temperature remained controlled at 44 degrees C and a synergistic cytotoxicity of paclitaxel and hyperthermia was observed in MCF-7 cells. Conclusion: Magnetic nanovesicles containing biphasic suspensions La0.75Sr0.25MnO3 and Fe3O4 nanoparticles encapsulating paclitaxel have potential for combined self-controlled hyperthermia and chemotherapy.</dc:description><dc:publisher>FUTURE MEDICINE LTD</dc:publisher><dc:date>2014-12-28T15:04:24Z</dc:date><dc:date>2014-12-28T15:04:24Z</dc:date><dc:date>2014</dc:date><dc:type>Article</dc:type><dc:identifier>NANOMEDICINE, 9(7)955-970</dc:identifier><dc:identifier>1743-5889</dc:identifier><dc:identifier>1748-6963</dc:identifier><dc:identifier>http://dx.doi.org/10.2217/NNM.13.90</dc:identifier><dc:identifier>http://dspace.library.iitb.ac.in/jspui/handle/100/16825</dc:identifier><dc:language>English</dc:language></oai_dc:dc>